Careers Contact Locations

OPKO Health, Inc.

  • Home
  • Who We Are
    • Our Vision
    • Our History
    • Our Leadership
  • What We Do
    • Overview
    • Our Products
    • Our Solutions
    • Our Technology
    • Our Research
    • Our Diagnostics
  • News & Media
    • Press Releases
    • Announcements
    • Events
    • Presentations
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact
  • Locations

OPKO Acquires ModeX Therapeutics

Learn More

Press Releases

News & Media

News & Media

  • Press Releases
  • Announcements
  • Events
  • Presentations

BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry

Jun 22, 2021

OPKO Health to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics

Jun 21, 2021

OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland

Jun 17, 2021

OPKO Health to Participate in the Jefferies Virtual Healthcare Conference

May 27, 2021

OPKO Health Reports Transfer of Licensed Rights to RAYALDEE® in Japan to Vifor

May 24, 2021

OPKO Health Enters into Exchange Agreements with Certain 4.5% Convertible Senior Noteholders

May 7, 2021

OPKO Health Reports 2021 First Quarter Business Highlights and Financial Results

Apr 28, 2021

Major League Soccer Renews with BioReference Laboratories as COVID-19 Testing Provider for Second Year

Apr 27, 2021

OPKO Health to Report First Quarter 2021 Financial Results on April 28, 2021

Apr 22, 2021

BioReference Laboratories Expands Its Major League Sports Relationships with Addition of Major League Baseball

Apr 1, 2021
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...47
    Next
    © 2022 OPKO Health, Inc. All Rights Reserved.
    Privacy Policy Governance Terms of Use Sitemap